Business News • PR NewsWire • Cardio3 BioSciences to Participate at the KBC Securities Benelux Biotech Healthcare Conference in New York on November 13 & 14

Cardio3 BioSciences to Participate at the KBC Securities Benelux Biotech Healthcare Conference in New York on November 13 & 14

Cardio3 BioSciences to Participate at the KBC Securities Benelux Biotech Healthcare Conference in New York on November 13 & 14

MONT-SAINT-GUIBERT, Belgium, October 14, 2013 /PRNewswire/ -- The Belgian biotechnology company Cardio3 BioSciences (C3BS), leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces its...

View More : http://www.prnewswire.com/news-releases/cardio3-biosciences-to-participate-at-the-kbc-securities-benelux-biotech-healthc...

Releted News by prnewswire

Cell Therapeutics Adds Three Leaders in Blood Cancer Research and Development to Scientific Advisory Board

Investcorp appoints Lionel Erdely as Head of Hedge Funds, Chief Investment Officer

Square Enix Announces KINGDOM HEARTS HD 2.5 ReMIX

Coms plc: Coms Wins "Best Performing Share of 2013"

Data Privacy Leader TRUSTe Appoints Ken Parnham as Managing Director EMEA